EUVIMEDEUVIMED entdecken
Crossref

Sensitive detection of prostate cancer antigen 3 (PCA3) in urine based upon CRISPR/Cas12a and gold nanorods (AuNRs)

Wenjie Liao, Shiqiang Li, Shaoyong Wu, Xiaosong Yang, Bo Liu, Liansheng Ling, Qiuyao Zeng, Ji Zhang

Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy · 2026-12 · 363 · 128309

DOI: 10.1016/j.saa.2026.128309 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2026-12. Verfasst von Wenjie Liao und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry, Sun Yat-Sen University, Guangzhou 510006, China. Hauptthemen laut MEDLINE: Gold, Nanotubes, Antigens, Neoplasm, Prostatic Neoplasms. Die Arbeit nennt 37 Literaturangaben. Gefördert von: Guangdong Provincial Natural Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostate Cancer Antigen 3, a type of long non-coding RNA, exhibits outstanding specificity as a biomarker for the diagnosis of prostate cancer, offering a highly effective diagnostic indicator, whereas the currently used prostate specific antigen exhibits low specificity, leading to reduced accuracy in prostate cancer diagnosis. Herein, we designed a novel fluorescent sensing platform for targeted detection of PCA3, which integrates the non-specific trans-cleavage activity of the CRISPR/Cas12a with the remarkable fluorescence quenching effect of Gold Nanorods. The Cas12a recognizes and binds to specific sequences of PCA3, thereby activating nonspecific cleavage activity, which cleaves fluorescent reporter probes adsorbed on AuNRs, thus leading to the recovery of fluorescence signals and enabling sensitive detection. The proposed fluorescent sensor exhibits excellent accuracy and convenience for the detection of PCA3 in urine, and a detection limit as low as 1.65 pM was obtained. This sensing system has achieved effective detection of clinical samples of prostate cancer and is expected to provide significant assistance in the screening and therapeutic feedback of prostate cancer in clinical diagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GoldNanotubesAntigens, NeoplasmProstatic NeoplasmsCRISPR-Cas SystemsCRISPR-Associated ProteinsBacterial ProteinsEndodeoxyribonucleasesHumansMaleLimit of DetectionSpectrometry, FluorescenceBiosensing TechniquesBiomarkers, Tumor

Stichwörter der Autor:innen

AuNRsCRISPR/Cas12aNonspecific cleavageProstate cancer antigen 3Urine test

Substanzen

Goldprostate cancer antigen 3, humanAntigens, NeoplasmCas12a proteinCRISPR-Associated ProteinsBiomarkers, TumorBacterial ProteinsEndodeoxyribonucleases

Autor:innen und Institutionen

  • School of Chemistry, Sun Yat-Sen University, Guangzhou 510006, China.
  • State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510006, China.
  • Chemistry and Chemical Engineering Guangdong Laboratory, Shantou 515031, China.
  • School of Chemistry, Sun Yat-Sen University, Guangzhou 510006, China. Electronic address: cesllsh@mail.sysu.edu.cn.
  • State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510006, China. Electronic address: Zengqiuy@sysucc.org.cn.
  • State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510006, China. Electronic address: zhangji@sysucc.org.cn.

Förderung

  • Guangdong Provincial Natural Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Liao, W., Li, S., Wu, S., Yang, X., Liu, B., Ling, L., Zeng, Q., & Zhang, J. (2026). Sensitive detection of prostate cancer antigen 3 (PCA3) in urine based upon CRISPR/Cas12a and gold nanorods (AuNRs). Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 363, 128309. https://doi.org/10.1016/j.saa.2026.128309

Vancouver

Liao W, Li S, Wu S, Yang X, Liu B, Ling L, et al. Sensitive detection of prostate cancer antigen 3 (PCA3) in urine based upon CRISPR/Cas12a and gold nanorods (AuNRs). Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 2026;363:128309. doi:10.1016/j.saa.2026.128309

BibTeX
@article{Liao2026,
  author = {Liao, Wenjie and Li, Shiqiang and Wu, Shaoyong and Yang, Xiaosong and Liu, Bo and Ling, Liansheng and Zeng, Qiuyao and Zhang, Ji},
  title = {Sensitive detection of prostate cancer antigen 3 (PCA3) in urine based upon CRISPR/Cas12a and gold nanorods (AuNRs)},
  journal = {Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy},
  year = {2026},
  volume = {363},
  pages = {128309},
  doi = {10.1016/j.saa.2026.128309}
}
Kostenlos starten →